Romvimza Interactions
There are 136 drugs known to interact with Romvimza (vimseltinib), along with 2 disease interactions. Of the total drug interactions, 15 are major, 115 are moderate, and 6 are minor.
- View Romvimza disease interactions (2)
Medications known to interact with Romvimza
Note: Showing generic names only.
- afatinib
- aliskiren
- alpelisib
- ambrisentan
- apixaban
- artesunate
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- atorvastatin
- dabigatran
- daclizumab
- dalfampridine
- darolutamide
- daunorubicin
- daunorubicin liposomal
- dextromethorphan
- digoxin
- docetaxel
- dofetilide
- doxorubicin
- doxorubicin liposomal
- edoxaban
- efavirenz
- elagolix
- enfortumab vedotin
- epirubicin
- erlotinib
- erythromycin
- etoposide
- etranacogene dezaparvovec
- everolimus
- idarubicin
- idelalisib
- imatinib
- indacaterol
- interferon beta-1a
- interferon beta-1b
- irinotecan
- isoniazid
- lapatinib
- larotrectinib
- leflunomide
- lemborexant
- levoketoconazole
- lomitapide
- loperamide
- lurasidone
- lusutrombopag
- paclitaxel
- paclitaxel protein-bound
- pazopanib
- pegaspargase
- peginterferon beta-1a
- pexidartinib
- pitavastatin
- posaconazole
- pralsetinib
- prazosin
- procainamide
- ranolazine
- relugolix
- remdesivir
- repotrectinib
- rifampin
- rifaximin
- rimegepant
- riociguat
- ripretinib
- ritonavir
- rivaroxaban
- romidepsin
- rosuvastatin
- tacrolimus
- talazoparib
- tenofovir alafenamide
- tenofovir disoproxil
- terfenadine
- teriflunomide
- thioguanine
- tipranavir
- tolvaptan
- topotecan
- trabectedin
Romvimza disease interactions
There are 2 disease interactions with Romvimza (vimseltinib) which include:
Report options
More about Romvimza (vimseltinib)
- Romvimza consumer information
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Turalio
Turalio (pexidartinib) is a kinase inhibitor for the treatment of tenosynovial giant cell tumor ...
Abecma
Abecma is a CAR T cell therapy used to treat relapsed refractory multiple myeloma (RRMM); it is a ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Accutane
Accutane (isotretinoin) is a form of vitamin A and is used to treat severe nodular acne. Includes ...
Adstiladrin
Adstiladrin (nadofaragene firadenovec-vncg) is a gene therapy used to treat high-risk Bacillus ...
Amnesteem
Amnesteem is used for acne, acute nonlymphocytic leukemia, granuloma annulare, rosacea
Amtagvi
Amtagvi (lifileucel) is a type of medicine called “tumor-derived autologous T cell immunotherapy” th ...
Anktiva
Anktiva (N-803) is used to treat specific types of bladder cancer. It is FDA-approved to be used ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.